Ciprofloxacin (Cipro Inhale, BAYQ3939)
Sponsors
Bayer
Conditions
Cystic FibrosisDisease, PulmonaryRespiratory System
Phase 1
Study to Evaluate the Safety and Pharmacokinetics of Inhaled Ciprofloxacin in Patients With Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD)
CompletedNCT01052298
Start: 2009-04-30End: 2009-09-30Updated: 2013-05-30
Study to Characterize Lung Deposition, Pharmacokinetics, Safety and Tolerability of Single Inhalations of Radiolabeled Ciprofloxacin Dry Powder in Healthy Subjects and Patients With Chronic Lung Diseases
CompletedNCT01538667
Start: 2012-04-30End: 2012-07-31Updated: 2014-08-21